Sign In
Buy INFU
$9.14
-0.0500 (-0.544%)
At Close: Jul 31, 2026
InfuSystem Holdings Inc. (INFU) CEO Rich DiIorio on Q1 2021 Results - Earnings Call Transcript
12:12pm, Sunday, 09'th May 2021
InfuSystem Holdings Inc. (INFU) CEO Rich DiIorio on Q1 2021 Results - Earnings Call Transcript
InfuSystem Reports First Quarter 2021 Financial Results
06:31am, Thursday, 06'th May 2021
Net Revenues: $24.5 million, a 14% increase Net Income: $0.7 million, a $1.1 million increase, Adjusted EBITDA: $6.2 million, a 51% increase, and Adjusted EBITDA margin of 25.2%, a 6.3% increase
InfuSystem to Report First Quarter 2021 Financial Results on Thursday, May 6, 2021
04:10pm, Thursday, 29'th Apr 2021
Investor Conference Call to be held 9:00 a.m. Eastern Time Investor Conference Call to be held 9:00 a.m. Eastern Time
InfuSystem Acquires OB Healthcare Corporation, Expanding DME Services Platform in Acute Care
06:31am, Wednesday, 21'st Apr 2021
ROCHESTER HILLS, Michigan, April 21, 2021 (GLOBE NEWSWIRE) -- InfuSystem Holdings, Inc. (NYSE American: INFU), (“InfuSystem” or the “Company), a leading national health care service provider,
InfuSystem's Continued Execution Could Lead It To Double
02:51am, Wednesday, 24'th Mar 2021
InfuSystem's Continued Execution Could Lead It To Double
InfuSystem to Present at Sidoti's Spring 2021 Virtual Conference March 25, 2021
05:30pm, Monday, 22'nd Mar 2021
Investor Presentation to be held 9:15 a.m. Eastern Time Investor Presentation to be held 9:15 a.m. Eastern Time
InfuSystem Holdings Inc.'s (INFU) CEO Rich Dilorio on Q4 2020 Results - Earnings Call Transcript
01:47pm, Wednesday, 17'th Mar 2021
InfuSystem Holdings Inc.'s (INFU) CEO Rich Dilorio on Q4 2020 Results - Earnings Call Transcript
InfuSystem Reports Fourth Quarter and Full Year 2020 Financial Results
06:30am, Wednesday, 17'th Mar 2021
Full Year 2020 vs. Full Year 2019: Net Revenues: $97.4 million, a 20% increase Net Income: $17.3 million, a 15.9 million increase, Adjusted EBITDA: $26.2 million, a 44% increase, and Adjusted EBITDA m
InfuSystem to Report Fourth Quarter and Full Year 2020 Financial Results on Wednesday, March 17, 2021
06:30am, Monday, 08'th Mar 2021
Investor Conference Call to be held 9:00 a.m. Eastern Time Investor Conference Call to be held 9:00 a.m. Eastern Time
InfuSystem Announces Appointment of Carrie Lachance as President
06:30am, Tuesday, 02'nd Mar 2021
ROCHESTER HILLS, Michigan, March 02, 2021 (GLOBE NEWSWIRE) -- InfuSystem Holdings, Inc. (NYSE American: INFU), (“InfuSystem” or the “Company), a leading national health care service provider, fa
InfuSystem Announces New $75 Million Revolving Credit Facility
06:30am, Thursday, 11'th Feb 2021
RODCHESTER HILLS, Michigan, Feb. 11, 2021 (GLOBE NEWSWIRE) -- InfuSystem Holdings, Inc. (NYSE American: INFU), (“InfuSystem” or the “Company), a leading national health care service provider, fa
InfuSystem Acquires Biomedical Services Company to Expand DME Services Platform
06:31am, Wednesday, 03'rd Feb 2021
Rochester Hills, Michigan, Feb. 03, 2021 (GLOBE NEWSWIRE) -- InfuSystem Holdings, Inc. (NYSE American: INFU), (“InfuSystem” or the “Company), a leading national health care service provider, f
A Trio of Small Caps for the Growth-Focused Investor
10:13am, Thursday, 07'th Jan 2021
Growth-focused investors may be interested in the following small-cap stocks, as they represent companies whose trailing 12-month earnings per share improved significantly on a year-over-year basis.
InfuSystem: Strength In Core Businesses Hedges Against COVID-19 Headwinds
09:13am, Wednesday, 23'rd Dec 2020
InfuSystem is uniquely positioned to benefit from any resurgence in COVID-19, and ex-COVID has strength in the core business model. Shareholders have enjoyed ~120% upside YTD, and shares have the legs
InfuSystem Holdings, Inc. Issues Full Year 2021 Guidance
06:30am, Tuesday, 15'th Dec 2020
Revenues of $107 million - $110 million; Adjusted EBITDA of $29 million - $30 million; Operating Cash Flow of $21 million - $23 million; Revenues of $107 million - $110 million; Adjusted EBITDA of
